Medtronic neurostimulation portfolio
This article was originally published in The Gray Sheet
Executive Summary
Firm launches its SynergyPlus+ neurostimulation system, which allows patients to program up to 26 levels of chronic pain treatment, according to a June 15 release. The non-rechargeable, remote-controlled device gained approval through a PMA supplement in April. The product joins Medtronic's first-generation Synergy system and Restore rechargeable system. Indications include low back syndrome, degenerative disc disease, post laminectomy pain and unsuccessful disc surgery. Medtronic estimates 70 mil. people in the U.S. suffer from chronic pain...